The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major ...

Transcranial Magnetic Stimulation (TMS) is a non-invasive therapy that utilizes magnetic fields to stimulate nerve cells in the brain, particularly targeting regions responsible for mood ...

TRICARE recently announced coverage of Transcranial Magnetic Stimulation (TMS) as a treatment for major depressive disorder. TMS is used when other depression treatments have not been effective.

Dr. Blair and Optimum TMS, utilize the most technologically advanced treatment for those individuals suffering from treatment resistant depression, transcranial magnetic stimulation, or "TMS." ...

This approval marks NeuroStar as the first and only transcranial magnetic stimulation (TMS) therapy cleared by the FDA for use in this younger demographic, expanding its indications to a fourth ...

Transcranial magnetic stimulation (TMS) is a non-invasive therapy that helps "rewire your brain," said Richard Pucci, chief ...

TMS Co., Ltd. (JP:4891) has released an update. TMS Co., Ltd. has secured a U.S. patent for a new treatment for acute kidney injury using compounds including TMS-008, further strengthening its ...

Participants were assigned to either an active Deep TMS or sham treatment arm for a five-day period, followed by a nine-week washout, before crossing over to the other arm. The study’s primary ...